title: Therapy: This time it's personal.
authors.forename: Lauren
authors.initials: L
authors.lastname: Gravitz
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use; D005075:Biological Evolution; D001706:Biopsy / Q000379:methods; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000097:blood / Q000235:genetics; D018450:Disease Progression; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D016147:Genes, Tumor Suppressor; D005826:Genetics, Medical / Q000639:trends; D023281:Genomics / Q000639:trends; D006801:Humans; D000068877:Imatinib Mesylate; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D008875:Middle Aged; D053758:Nanoparticles / Q000008:administration & dosage; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy*; D010597:Pharmacogenetics / Q000639:trends; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D057285:Precision Medicine / Q000379:methods* / Q000639:trends*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors; D059467:Transcriptome; D000077484:Vemurafenib
chemical_list: D001549:Benzamides; D004273:DNA, Neoplasm; D007211:Indoles; D010879:Piperazines; D011743:Pyrimidines; D034741:RNA, Small Interfering; D013449:Sulfonamides; D000077484:Vemurafenib; D000068877:Imatinib Mesylate; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf